Find out more about a novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell therapy applications.
Find out more about our Vector-free intracellular delivery by reversible permeabilization.
Watch our informative video and find out more about the Avectas Solupore SUS system and how it is used.
Find out how Solupore® by Avectas offers an automated, reproducible transfection system for the delivery of a wide variety of cargo (RNA, DNA, protein) to primary immune cells used in clinical cell therapy applications.
Download our PDF and see how Solupore is accelerating the future of cell therapies through healthier and more functional cells for patients.
Solupore® Triple Knock-Out Transfected T cell Expansion Equivalent to Untransfected in G-Rex® Platform.
Solupore® demonstrates superior cellular avidity which is essential for optimising cell therapy processes.
Solupore® Triple Knock-Out Transfected T cell Expansion Equivalent to Untransfected in G-Rex Platform
Enhanced Stem Cell Memory and Cytotoxic Function in Engineered T Cells Expanded for 7 days to >1.3×109
Solupore® knock-in using GenScript GenExact™ single-stranded DNA
Activation-Free Transfection with Solupore®: Preserving Naïve T cell Phenotypes
Increased functional potency of multi-edited CAR-T cells manufactured by a non-viraltransfection system.